Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR
· Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT
Monopar Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.08B | -2.62M | -10.93M | -1.3K | -1.72M | -1.64M | -1.81M | -1.95M | -2.2M | -2.43M | -2.9M | -2.4M | -2.76M | -2.46M | -2.68M | -2.46M | -2.08M | -1.88M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.28B | 1.36M | 278.61K | 861.84M | 334.39K | 328.66K | 474.21K | 474.14K | 473.3K | 476.21K | 393.42K | 390.74K | 357.29K | 499.81K | 350.16K | 392.06K | 357.59K | 368.23K |
Other Working Capital | 3.62M | -3.62M | 2.96M | 2.96K | 49.87K | -31.62K | 6.81K | 36.67K | -3.05K | -60.84K | 5.25K | 4.49K | 2.58K | 21.73K | -42.09K | -11.24K | 19K | -51.88K |
Other Non-Cash Items | -2.94B | n/a | 4.55M | -863.55M | n/a | n/a | n/a | n/a | 845.02K | 728.13K | -802.45K | -277.53 | -734.99K | 1.03M | 9.55K | 255.77K | 60.14K | 738.63K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.39M | -4.39M | 4.1M | 638.74K | -295.88K | -342.86K | -206.19K | -460.22K | -374.77K | -312.77K | 1.2M | -139.57K | 1.09M | -510.59K | 298.52K | 125.06K | 316.46K | -422.27K |
Operating Cash Flow | -6.74B | -5.66M | -2M | -1.07M | -1.68M | -1.66M | -1.55M | -1.94M | -2.1M | -2.27M | -1.3M | -2.15M | -1.31M | -2.47M | -2.03M | -1.94M | -1.41M | -1.94M |
Capital Expenditures | 4.00 | -4 | n/a | n/a | n/a | 3.00 | n/a | 3.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -3.14B | -1.93M | -14.34M | n/a | -2.42K | -983.31K | 9.24K | -2.97M | -1.96M | -2.96M | -4.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 4B | 1.6M | n/a | 985.73K | n/a | n/a | 2.96M | 2.96M | 4.92M | 1.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.95K | -983.44 | -4.92K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 861.79M | -325.83K | -14.34M | 985.73K | -2.42K | -983.31K | 2.97M | -13.05K | 2.95M | -983.44K | -4.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -16.53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.67K | -29.66 | -16.67 | -7.77 | -9.98 | -24 | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -432.41M | -131.13K | -66.95K | -16.52K | -10K | -10.74K | -5.32K | -8.21K | -16.61K | -16.83K | 29.4K | -13.07K | -65.46K | -16.67K | -7.77K | -9.98K | -24K | -4.02K |
Financial Cash Flow | -432.41M | -115.68K | 56.14M | -16.53K | -9.92K | 3.18M | 334.55K | 246.7K | 641.18K | 804.8K | 138.74K | -23.74K | -65.46K | -16.67K | -7.77K | -9.98K | -24K | 10.92M |
Net Cash Flow | 39.46B | -6.1M | 39.8M | -99.85K | -1.69M | 541.5K | 1.75M | -1.7M | 1.49M | -2.46M | -6.13M | -2.15M | -1.36M | -2.48M | -2.04M | -1.95M | -1.43M | 8.99M |
Free Cash Flow | -6.74B | -5.66M | -2M | -1.07M | -1.68M | -1.66M | -1.55M | -1.94M | -2.1M | -2.27M | -1.3M | -2.15M | -1.31M | -2.47M | -2.03M | -1.94M | -1.41M | -1.94M |